Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

18.35USD
5:42pm BST
Change (% chg)

$-0.24 (-1.29%)
Prev Close
$18.59
Open
$18.49
Day's High
$18.90
Day's Low
$17.94
Volume
41,272
Avg. Vol
161,663
52-wk High
$31.69
52-wk Low
$12.51

Chart for

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

No Ratios Available.

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -- -- --
ROI: -- 15.07 14.61
ROE: -- 16.60 16.34

BRIEF-Apellis Pharmaceuticals Announces 18-Month Results Of Phase 2 Study Of APL-2 In Geographic Atrophy

* APELLIS PHARMACEUTICALS ANNOUNCES 18-MONTH RESULTS OF PHASE 2 STUDY (FILLY) OF APL-2 IN GEOGRAPHIC ATROPHY Source text for Eikon: Further company coverage:

22 Feb 2018

Earnings vs. Estimates